National guidelines recommend screening for latent tuberculosis infection (LTBI) in all HIV-infected patients. Thus, the objective of this study was to measure protocol adherence to national guidelines regarding LTBI screening for HIV-infected patients entering care at an urban primary care clinic specializing in HIV care, identify clinical and other characteristics associated with adherence, and determine whether transitioning from the tuberculin skin test (TST) to the interferon-gamma release assay (IGRA) improved adherence. We conducted a retrospective study using protocol adherence to LTBI screening guidelines within twelve months of entering care at an HIV clinic as the primary outcome. Successful protocol adherence was defined as the placement and reading of a TST, performance of an IGRA, or a note in study clinic records documenting prior testing or treatment for tuberculosis in an outside setting. Multivariable modified Poisson regression models were used in analyses. Overall, 32% (n = 118/372) of patients received LTBI screening within twelve months of entering care. Protocol adherence to LTBI screening guidelines increased from 28% to 37% following the transition from TST to IGRA screening. IGRA screening [adjusted prevalence ratio: 1.45, 95% confidence limits: (1.07, 1.96)], male sex [1.47 (1.05, 2.07)], transfer patient status [1.51 (1.05, 2.18)], and greater than one year of clinic attendance [1.62 (1.06, 2.48)] were independently associated with protocol adherence. Among patients without prior LTBI screening or treatment, patients entering the clinic in 2013 under the IGRA screening protocol were more likely to be screened for LTBI compared to patients entering under the TST screening protocol (34.3% vs. 9.7%, p < 0.001). In conclusion, transitioning from TST to IGRAbased screening improved adherence to screening guidelines. However, further work on improving adherence to LTBI screening guidelines among HIV-infected patients is needed.
Introduction
Globally, tuberculosis (TB) is the leading cause of death for persons living with HIV/AIDS (World Health Organization, 2015) . While antiretroviral therapy has markedly decreased the incidence of concurrent HIV/TB infection in the United States, the risk of active TB among HIVinfected individuals remains twice that of the general population (Horsburgh, 2004) . HIV-infected individuals are more likely to progress from latent to active TB and are at increased risk of developing multi-drug resistant TB, extrapulmonary manifestations, and disseminated disease compared to HIV-uninfected individuals (Corbett et al., 2003; Talati et al., 2011) . Therefore, national guidelines strongly endorse screening and treatment of latent tuberculosis infection (LTBI) in HIV-infected patients (Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2016).
In 2012, an HIV primary care clinic in Philadelphia, Pennsylvania transitioned from tuberculin skin test (TST) to interferon-gamma release assay (IGRA)-based screening. This transition provided an opportunity to compare protocol adherence to national guidelines based on the LTBI screening method. Thus, the objective of this retrospective study was to measure protocol adherence and identify clinical and other characteristics associated with adherence. We hypothesized that the transition to IGRA-based screening would improve adherence due to logistical advantages of the IGRA method (Cattamanchi et al., 2011; Foster-Chang, Manning, & Chandler, 2014; Linas, Wong, Freedberg, & Horsburgh, 2011) . January-December 2013. Patients were classified as transferring HIV care when a recorded CD4 or HIV viral load result from another outpatient setting preceded the initial visit to the study clinic. This observational, retrospective study was approved by the Institutional Review Board at Drexel University College of Medicine.
Data collection

Primary exposure
The primary exposure was entering care from January-December 2013 during IGRA-based screening versus entering care from January-December 2010 during TST-based screening.
Outcome
The outcome was protocol adherence to LTBI screening guidelines at the study clinic at or within the twelve months following the first clinic visit. Medical charts for enrolled patients were reviewed for a year following the initial visit by trained investigators. Successful protocol adherence was defined as the placement and reading of a TST, performance of an IGRA, or a note in study clinic records documenting prior testing or treatment for tuberculosis in an outside setting.
Secondary exposures and covariates
Secondary exposures and covariates included characteristics previously shown to be associated with LTBI screening (Backus et al., 2010; Lee, Lobato, Buskin, , & Costa, 2006) including CD4 count, receipt of antiretroviral therapy, clinic attendance, and sociodemographic characteristics.
Morse
Statistical analysis
We performed χ 2 analyses, t-tests, and Wilcoxon ranksum tests to assess associations between sociodemographic and clinical characteristics with testing method and protocol adherence to screening guidelines. We then performed unadjusted and adjusted analyses using modified Poisson regression models to estimate associations with adherence to guidelines (McNutt, Wu, Xue, & Hafner, 2003; Zou, 2004) . Statistical analyses were performed using SAS (Version 9.3, SAS Institute, Inc., Cary, NC).
Results
A total of 272 patients were identified as new to the clinic from December-January 2010 and 178 patients as new from December-January 2013. We excluded patients with a single visit (n = 41), patients missing baseline CD4 counts (n = 31), and transgender individuals (n = 5), resulting in a total study population of 372. Demographic, behavioral, and clinical characteristics are presented in Table 1 . Patients entering the study clinic were mostly male, non-Hispanic Black or White, transferring HIV care, and had an initial CD4 count >350 cells/uL. A significantly greater proportion of patients in 2013 were Black, non-smokers, living independently, on ART with significantly lower HIV RNA levels and higher CD4 cell counts by the end of followup.
Overall, 31.7% of patients received care adhering to LTBI screening guidelines: 27.9% of patients entering care in 2010 and 37.3% of patients entering care in 2013 (Figure 1 ). Of the 67 screening tests performed at the study clinic during both years, one patient had a positive TST result. This patient self-reported a previous positive TST result; however, there was no record of previous LTBI screening within clinic records. A follow-up chest radiograph showed no acute lung disease. Individuals with no signs of active TB disease who test positive for LTBI typically receive treatment to prevent active TB disease and the associated risk of TB-related morbidity and mortality (Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2016).
In adjusted analyses ( 
Discussion
Screening for latent tuberculosis infection is an essential component of preventive care for HV-infected patients (Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2016). We found that 68% of HIV-infected new patients at an HIV primary clinic in Philadelphia did not receive care adhering to national guidelines on LTBI screening. Our study is the first to show that a transition from TST to IGRA-based screening within an HIV primary care clinic significantly improved protocol adherence; however, adherence remained low. Protocol adherence was also significantly positively associated with male gender, transfer patient status, and clinic attendance for more than a year. These findings suggest that further research is needed on how to most effectively improve adherence to LTBI screening guidelines in HIV primary care settings.
Progress over the past two decades toward TB elimination has decreased TB incidence from 10.5 cases per 100,000 in 1992 to 3.0 per 100,000 in 2015 (Centers for Disease & Prevention, 1993; Salinas et al., 2016) . While the incidence of active tuberculosis has decreased in recent years, Philadelphia reported 71 cases of active TB in 2015 and 12% were co-infected with HIV (Philadelphia Department of Public Health, 2015). The coinfection rate is more than double the national average and highlights the continued need for screening in this clinic setting (Philadelphia Department of Public Health, 2015) . LTBI screening remains a vital and low-cost component of HIV preventive care.
Previous studies with healthcare workers have demonstrated the advantages of IGRA-based over TSTbased screening (Shah et al., 2012; Wrighton-Smith, Sneed, Humphrey, Tao, & Bernacki, 2012) . A 2014 study found that adoption of IGRA-based screening increased compliance to employee screening guidelines at a medical center from 77% to 97% and reduced screening-associated costs (Foster-Chang et al., 2014) . Within our study, screening tests performed at the study clinic increased from 7% to 33% following the transition to IGRA-based screening. Logistical advantages associated with IGRA such as testing within a single visit may help explain this finding.
Within our study population, women were significantly less likely to be screened compared to men. Unfortunately, gender disparities in HIV-care outcomes are common (Aziz & Smith, 2011; Shapiro et al., 1999) . Women-focused HIV care that addresses these barriers may help decrease disparities (Aziz & Smith, 2011) . Patients transferring HIV care and patients who remained at the study clinic for over a year were significantly more likely to have received care adhering to guidelines. However, transfer patient status and clinic attendance for more than one year no longer significantly impacted adherence when analysis was limited to patients without prior evidence of LTBI screening or treatment (results not shown).
Limitations of this study include the use of medical records and reliance on the completeness and validity of these records. We did not include health insurance coverage as an exposure, and type of coverage may have influenced screening. Not accounting for other factors including travel history, birthplace, or immigration status in analyses may have impacted results. We were unable to disentangle the impact of screening method and period effects. A change in clinic workflow or in healthcare providers across periods may have impacted screening. LTBI screenings received under the TST screening protocol could have been IGRA as outside clinics may have adopted IGRA earlier than the study clinic. Finally, the study sample was selected from one HIV clinic in Philadelphia and results may not be generalizable to other HIV-infected populations, particularly those living outside the United States. However, sociodemographic attributes of our study population are very similar to those of HIV-infected populations living in other economically disadvantaged urban areas in the United States including Baltimore, Newark, and New Orleans (Laffoon et al., 2015) . Therefore, our findings may generalize to other urban HIV-infected populations in the United States. Despite these limitations, this is the first study to examine the impact of transitioning from TST to IGRA-based screening on protocol adherence for HIV-infected patients.
In summary, this study found poor protocol adherence to LTBI screening guidelines for HIV-infected patients at an urban HIV clinic. Furthermore, protocol adherence was associated with IGRA-based screening, male sex, transfer patient status, and remaining a patient at the clinic for over a year. The observed poor protocol adherence suggests a change in clinic policy regarding LTBI screening may be needed.
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